Anti-epidermal growth factor receptor antibodies and uses thereof
US8486895B2 · kind B2 · utility
5Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2009 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Dec 30, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention discloses humanized anti-epidermal growth factor receptor antibodies, which have favorable binding activity (the binding affinity being 5.09×10−10 mol/L) and are able to inhibit the growth and migration of tumor cells. The present invention also discloses the preparation methods and uses of the antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.